Clinical Trial: A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent(R), and EU-Dupixent(R) in Healthy Adult Participants.

U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07358156) titled 'A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent(R), and EU-Dupixent(R) in Healthy Adult Participants.' on Jan. 14.

Brief Summary: This is a randomised, double-blind, three-arm, parallel group, single-dose, Phase 1 comparative study of CKD-706, US-Dupixent, and EU-Dupixent in healthy adult participants.

Study Start Date: Feb. 09

Study Type: INTERVENTIONAL

Condition: Pharmacokinetic, Pharmacodynamic Profile and Safety

Intervention: DRUG: CKD-706

One subcutaneous dose of CKD-706 in pre-filled syringe, 300 mg/2mL

DRUG: US-Dupixent

One subcutaneous dose of US-Dupix...